In this exclusive interview, Dr. Olatunji Alese delves into the pivotal moments that shaped his journey—from his grandmother’s battle with liver cancer to his involvement in landmark clinical trials. He discusses his passion for advancing precision medicine, the importance of addressing health disparities among younger and minority populations, and the urgent need to expand clinical trial access. Offering mentorship insights for aspiring GI oncologists, Dr. Alese outlines why loving what you do and aligning with strong mentors are crucial for a rewarding academic career.
Latest News
Short-term radiotherapy with sintilimab and capecitabine/oxaliplatin as a total neoadjuvant treatment can increase pCR rates.
Dr. Despina Siolas reflects on her career as a GI oncologist, her role as a mentor to young people in the field, and more.
Researchers examined how physicians used TNT for rectal cancer in real-world settings outside clinical trials.
Dr. Sanjay Juneja moderated a thoughtful panel discussion on the challenges of optimizing chemo strategies in GI cancers.
In two trials, researchers compared the efficacy of surgery and radiofrequency ablation for patients with liver cancer.
Investigators examined the recurrence patterns among patients from the ESOPEC trial who underwent tumor resection.
Dr. Perez breaks down her study that investigated the use of ramucirumab and somatostatin in patients with advanced NETs.
The ACCORD trial evaluated the efficacy of combined IO and radiotherapy in patients with resectable biliary tract cancers.
Dr. Chakrabarti highlights 100% response with PD-1 blockade in dMMR rectal cancer and new chemoimmunotherapy for anal cancer.
Dr. Chakrabarti shares BREAKWATER, CheckMate 8HW, and CHALLENGE results improving metastatic colorectal cancer outcomes.